ISIN | CH1306848503 |
---|---|
Valor Number | 130684850 |
Bloomberg Global ID | |
Fund Name | BCV EQUITY FUND - BCV SPI 20 ZP |
Fund Provider |
BCV
Lausanne, Switzerland Phone: +41 848 808 880 E-Mail: info@bcv.ch Web: www.bcv.ch |
Fund Provider | BCV |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The objective of BCV SPI 20 is to generate a capital gain over the long term by investing in equity securities and ledger-based securities (shares, dividend warrants, cooperative shares, participation certificates and similar securities) of companies that have their registered office in Switzerland or carry out the majority of their economic activity there and are part of the SPI® index. The sub-fund has a small diversification and seeks the best investment opportunities through a management approach combining qualitative, fundamental, and behavioural analysis. |
Peculiarities |
Current Price * | 109.06 CHF | 01.11.2024 |
---|---|---|
Previous Price * | 107.49 CHF | 31.10.2024 |
52 Week High * | 113.64 CHF | 02.09.2024 |
52 Week Low * | 98.45 CHF | 09.02.2024 |
NAV * | 109.06 CHF | 01.11.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 132,169,435 | |
Unit/Share Assets *** | 124,600,093 | |
Trading Information SIX |
YTD Performance | - | - |
---|---|---|
1 month | -1.10% |
01.10.2024 - 01.11.2024
01.10.2024 01.11.2024 |
3 months | +0.36% |
02.08.2024 - 01.11.2024
02.08.2024 01.11.2024 |
6 months | +7.01% |
02.05.2024 - 01.11.2024
02.05.2024 01.11.2024 |
1 year | +9.06% |
09.01.2024 - 01.11.2024
09.01.2024 01.11.2024 |
2 years | - | - |
3 years | - | - |
5 years | - | - |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 17.99% | |
---|---|---|
Roche Holding AG | 16.43% | |
Novartis AG Registered Shares | 16.05% | |
UBS Group AG | 6.40% | |
Zurich Insurance Group AG | 5.63% | |
Compagnie Financiere Richemont SA Class A | 5.45% | |
ABB Ltd | 4.87% | |
Sika AG | 3.78% | |
Lonza Group Ltd | 3.12% | |
Alcon Inc | 3.10% | |
Last data update | 31.08.2024 |
TER | |
---|---|
TER date | |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.25% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |